Ken Valenzano, VP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), bought 15,000 shares at $8.00 ($120K) on 2014-11-25, disclosed to the SEC on 2014-11-25.
Scheduled purchase ($120k) by VP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 5,000 | $40K | 33.3% |
| 2 | $8.00 | 10,000 | $80K | 66.7% |
| Total | $8.00 avg | 15,000 | $120K | 100% |
| Filing → |
| FOLD | SELL | 2015-05-12 | $141K | — | Filing → |
| FOLD | SELL | 2015-04-17 | $63K | — | Filing → |
| FOLD | SELL | 2015-03-25 | $91K | — | Filing → |